Effect of Naoshuming decoction on expression of NF-κB, TNF-α, and IL-1β in focal cerebral ischemia rats.
10.11817/j.issn.1672-7347.2019.190459
- Author:
Bowei CHEN
1
;
Ping JIA
1
;
Wenjiang ZHANG
1
;
Jian YI
1
;
Baiyan LIU
1
;
Jinghua CHEN
2
Author Information
1. Key Laboratory of Internal Medicine of Chinese Medicine, First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410208, China.
2. Shenzhen Beikelian Pharmaceutical Technology Limited Liability Company, Shenzhen 518000, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Brain Ischemia;
Infarction, Middle Cerebral Artery;
Inflammation;
Interleukin-1beta;
NF-kappa B;
Rats;
Tumor Necrosis Factor-alpha
- From:
Journal of Central South University(Medical Sciences)
2019;44(11):1222-1229
- CountryChina
- Language:Chinese
-
Abstract:
To explore the effect of Naoshuming decoction on cerebral ischemic rats.
Methods: The model of cerebral ischemia in rats was established via middle cerebral artery occlusion (MCAO). The MCAO model rats were randomly divided into a model group (n=36), a Naoshuming decoction at high dose group (n=36), a Naoshuming decoction at middle dose group (n=36) and a Naoshuming decoction at low dose group (n=36). In addition, a normal group (n=12) and a sham operation group (n=12) were included. Rats in each group were killed on the 3rd, 7th, and 14th day to detect relevant indicators. The Ayelet Levy 14 method was used to score the neurological function. Immunohistochemical method was used to detect the protein expression of nuclear factor kappa-B (NF-κB)/p50, NF-κB/p65, tumor necrosis factor-α (TNF-α), and IL-1β. The quantitative real-time PCR were used to detect the mRNA expression of NF-κB, TNF-α and IL-1β.
Results: Compared with the sham group, at each time point, the inflammation indexes in the model group and different dose of Naoshuming decoction groups were significantly enhanced, and all of them showed neurological dysfunction. But the inflammatory indexes and neurological function scores would were gradually improved with the pass of time. Compared with the model group, the neurological dysfunction, the protein levels of NF-κB/p50, NF-κB/p65, TNF-α and IL-1β, and the mRNA of NF-κB, TNF-α and IL-1β in the high, middle and low dose of Naoshuming decoction groups were reduced at 3, 7 and 14 d, with statistical difference (all P<0.05 or P<0.01).
Conclusion: Naoshuming decoction can alleviate the cerebral ischemic injury in rats.
